Alembic is trading -4.14% lower at Rs 99.45 as compared to its last closing price. Alembic has been trading in the price range of 105.00 & 98.65. Alembic has given -24.29% in this year & -11.65% in the last 5 days. Alembic has TTM P/E ratio 10.75 as compared to the sector P/E of 15.77.The company posted a net profit of 65.39 Crores in its last quarter.Listed peers of Alembic include Gujarat Themis Biosyn (-4.36%), Solara Active Pharma Sciences (-2.79%), Alembic (-4.14%).The Mutual Fund holding in Alembic was at 3.36% in 30 Sep 2023. The MF holding has decreased from the last quarter. The FII holding in Alembic was at 1.78% in 31 Dec 2024. The FII holding has decreased from the last quarter.
Updated on Feb 17, 2025, 01:51 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Gujarat Themis Biosyn | Bearish | 249.15 | -4.36 | 2,714.87 | 45.89 | 13.48 | 0.27 | 0.61 |
Solara Active Pharma Sciences | Bearish | 488.05 | -2.79 | 2,655.60 | - | 2.05 | - | 12.58 |
Alembic | Bearish | 99.45 | -4.14 | 2,553.00 | 9.54 | 1.17 | 2.41 | 0.34 |
Suven Life Sciences | Bearish | 116.00 | -6.56 | 2,529.27 | - | 9.37 | - | - |
Vimta Labs | Bullish | 1,119.70 | 3.91 | 2,491.18 | 61.97 | 7.76 | 0.18 | 2.84 |
Meeting Date | Purpose |
---|---|
2025-02-07 | Quarterly Results & Other |
2024-11-08 | Quarterly Results & Other |
2024-08-12 | Quarterly Results |
2024-05-13 | Audited Results & Final Dividend |
2024-02-14 | Quarterly Results |
Alembic is trading at 99.45 as on Fri Feb 14 2025 09:59:45. This is -4.14% lower as compared to its previous closing price of 103.75.
The market capitalization of Alembic is 2553.00 Cr as on Fri Feb 14 2025 09:59:45.
The 52 wk high for Alembic is 169.00 whereas the 52 wk low is 78.20
Alembic can be analyzed on the following key metrics -
Alembic reported a net profit of 268.62 Cr in 2024.
The Mutual Fund Shareholding was 3.36% at the end of 30 Sep 2023.